13F
← All fund report cards

ING GROEP NV

13F equity value
$16.4B
Positions
503
Top 10 concentration
36.7%
Quarters / total new picks
32 / 2,480
13F equity value over time
$0M$9B$18B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +1.8% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 34.4% of quarters (excess t = -1.94, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-1.9%
t-stat
-1.94
Quarterly win rate
34%
Annualized excess
-3.9%
$1 → follow vs universe
$1.56 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.03220180630: follow 0.95220180930: follow 0.99220181231: follow 0.98320190331: follow 0.98120190630: follow 1.06320190930: follow 1.12720191231: follow 0.90720200331: follow 1.04320200630: follow 1.13420200930: follow 1.25020201231: follow 1.45920210331: follow 1.53320210630: follow 1.56320210930: follow 1.44820211231: follow 1.15920220331: follow 1.19820220630: follow 1.10520220930: follow 1.16720221231: follow 1.07920230331: follow 1.12620230630: follow 1.14320230930: follow 1.27620231231: follow 1.32120240331: follow 1.29120240630: follow 1.41420240930: follow 1.36920241231: follow 1.32220250331: follow 1.37320250630: follow 1.39220250930: follow 1.57020251231: follow 1.559 0.83 1.54 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 503 · 2026 Q1

Ticker Value Weight QoQ
NVDA $1.5B
9.0%
TRIM
MSFT $862M
5.3%
ADD
AAPL $672M
4.1%
TRIM
GOOG $579M
3.5%
ADD
GOOGL $552M
3.4%
ADD
AVGO $475M
2.9%
TRIM
MA $470M
2.9%
TRIM
AMZN $322M
2.0%
ADD
HON $297M
1.8%
ADD
MU $295M
1.8%
ADD
BAC $280M
1.7%
HOLD
META $240M
1.5%
ADD
HD $234M
1.4%
ADD
XLI $230M
1.4%
HOLD
TSLA $223M
1.4%
ADD
LIN $214M
1.3%
TRIM
LLY $179M
1.1%
ADD
CAR $179M
1.1%
ADD
PEP $161M
1.0%
ADD
IBM $159M
1.0%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.